This is from 30 Jul CEO Whelan on Facebook: << There is an agreement that requires our silence. That is all I can say. >> The following post, in reference to this statement, is my OPINION, nothing more. From this short two sentence response an opaque curtain has descended upon BIEL. We will be lucky if anything gets out let alone anything of substance except, obviously, revealing the details of the agreement that prompted the response to begin with.
This message is the most non-contextual, ambiguous, plain vanilla, open-ended, aseptic message there could possibly be. Despite its’ simplicity, this statement has been carefully worded. No feeling, emotion, or anything to hang your hat on. There is nothing to date it. No time frame. Nothing apart from when was the last communication from CEO Whelan or other member of management. What could possibly generate (or cause) such a complete shutdown of any further discussion in response to ‘hey, why the silence’?
The word ‘agreement’ has at least three (3) possible meanings: an NDA, MOU, or a signed contract. There might be others but I’ll stick w/ those for now. In my last post (linked, #7387) I alluded to all the work required to gain acceptance into the NoPainAct (NPA); thousands of hours of work ‘behind the scenes’ involving dozens of agencies of every stripe; departments, working groups, certifications, meetings, legal-beagle stuff, etc. No matter how you look at it we are talking about a massive effort which in many cases is as opaque as the curtain that has been drawn.
The other unmistakeable message from my last post was the sheer amount of money that is to be made should there be widespread marketing and acceptance of BIEL’s PEMF products via the NPA as the standard-of-care for pain issues. The current revenue stream of BIEL is irrelevant. With ‘only’ 50 million units sold annually and a measly $20 profit per device you get $1 billion in PROFIT. With acceptance into the NPA you will probably get the VA, DOD, and insurance coverage, as well. This scenario is way more than possible; it’s probable. Besides the US market, throw in Europe, Asia, Cent. & S. America, Middle East, and Africa. Whether big pharma likes it or not, this level of potential attracts major players. Look at recent overall stock market activity. Companies are desperate. In the right hands, BIEL is a goldmine.
There have been numerous ‘911’ share events. At current prices, each one is about twenty cents, $0.20 The most recent was the only trade for the entire day!! Why and how did that happen when recent share activity has been in the millions? Were all of the ‘911’ trades bogus? All strictly random events? Is someone trying to convey some message? Who trades $0.20?
From Chanel5 - << Farma Hope is an Italian Online Pharmacy authorized by the Ministry of Health. https://www.farmahope.it/en/actipatchicco-kit...26308.html International - It appears ActiPatch is available thru them in Italy, UK, Spain, France, Germany & The Netherlands. >> These relationships are turning up on an intermittent basis and usually NOT coming directly from the company. Again, the opaque curtain. BIEL is a firmly established worldwide operation waiting to go to the next level w/ a well-financed partner.
And this from gimmee greenbacks - << BIEL coming in at over 154,000 reads.. https://investorshub.advfn.com/boards/most_read.aspx. >> Whether or not one chooses to acknowledge it, there is clear, significant interest in the company that offers widely popular PEMF products. People want what we have developed but getting into the NPA and/or insurance coverage is key. Or is BIEL, practically speaking, unreadable at this point? Conjecture rules the discussion for the time being.
And, for me at least, the most profound factor in the CEO making this response is that it conveys a sense that something VERY, VERY, BIG is going on. And breaking ranks, spilling the beans accidentally, could cost you and your company dearly. As in << deal of a lifetime … kind of thing >>. The longer the silence continues, the greater the risk of a leak. Then you have an uncontrollable situation that nobody wants. My suspicion is CEO Whelan waited until the silence became deafening for investors who, in turn, finally asked the question directly.
There are more than a few possibilities but, IN MY OPINION, the only truly qualifying event is a buyout (BO). Dare we consider multiple suitors? Another interpretation is having a production MOU agreement w/ Viant indicating a forthcoming need for large scale production in the very near future, e.g. - NPA. You must remember we are not selling product exclusively in the US, we have business relationships w/ companies, retail outlets and distributors around the world. Any potential BO candidate would be able to put all those under one roof, so to speak, and take care of all the necessary marketing to make Actipatch/RecoveryRx a household name.
There have been smaller, less noticeable clues to lead one to conclude there is much more happening under the surface than what appears. Like having a UPC code assigned to BIEL. Or BIEL making a 10 pack for hospitals. I have said before and I’ll say it again. BIEL is ripe for the picking right now, today, w/o any further development and/or marketing. But these things take time. Countless posters have laid out the case for BIEL to be acquired. Given the political climate and the tyrannical control TPTB have over medical practices, any potential buyer would necessarily have to tread very carefully. One, to maintain the element of surprise and, two, to reduce any possible outside influence to derail. Outside interference has occurred before and could very well rear its’ ugly head again. Lots of moving parts. The race is on.
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
This message is the most non-contextual, ambiguous, plain vanilla, open-ended, aseptic message there could possibly be. Despite its’ simplicity, this statement has been carefully worded. No feeling, emotion, or anything to hang your hat on. There is nothing to date it. No time frame. Nothing apart from when was the last communication from CEO Whelan or other member of management. What could possibly generate (or cause) such a complete shutdown of any further discussion in response to ‘hey, why the silence’?
The word ‘agreement’ has at least three (3) possible meanings: an NDA, MOU, or a signed contract. There might be others but I’ll stick w/ those for now. In my last post (linked, #7387) I alluded to all the work required to gain acceptance into the NoPainAct (NPA); thousands of hours of work ‘behind the scenes’ involving dozens of agencies of every stripe; departments, working groups, certifications, meetings, legal-beagle stuff, etc. No matter how you look at it we are talking about a massive effort which in many cases is as opaque as the curtain that has been drawn.
The other unmistakeable message from my last post was the sheer amount of money that is to be made should there be widespread marketing and acceptance of BIEL’s PEMF products via the NPA as the standard-of-care for pain issues. The current revenue stream of BIEL is irrelevant. With ‘only’ 50 million units sold annually and a measly $20 profit per device you get $1 billion in PROFIT. With acceptance into the NPA you will probably get the VA, DOD, and insurance coverage, as well. This scenario is way more than possible; it’s probable. Besides the US market, throw in Europe, Asia, Cent. & S. America, Middle East, and Africa. Whether big pharma likes it or not, this level of potential attracts major players. Look at recent overall stock market activity. Companies are desperate. In the right hands, BIEL is a goldmine.
There have been numerous ‘911’ share events. At current prices, each one is about twenty cents, $0.20 The most recent was the only trade for the entire day!! Why and how did that happen when recent share activity has been in the millions? Were all of the ‘911’ trades bogus? All strictly random events? Is someone trying to convey some message? Who trades $0.20?
From Chanel5 - << Farma Hope is an Italian Online Pharmacy authorized by the Ministry of Health. https://www.farmahope.it/en/actipatchicco-kit...26308.html International - It appears ActiPatch is available thru them in Italy, UK, Spain, France, Germany & The Netherlands. >> These relationships are turning up on an intermittent basis and usually NOT coming directly from the company. Again, the opaque curtain. BIEL is a firmly established worldwide operation waiting to go to the next level w/ a well-financed partner.
And this from gimmee greenbacks - << BIEL coming in at over 154,000 reads.. https://investorshub.advfn.com/boards/most_read.aspx. >> Whether or not one chooses to acknowledge it, there is clear, significant interest in the company that offers widely popular PEMF products. People want what we have developed but getting into the NPA and/or insurance coverage is key. Or is BIEL, practically speaking, unreadable at this point? Conjecture rules the discussion for the time being.
And, for me at least, the most profound factor in the CEO making this response is that it conveys a sense that something VERY, VERY, BIG is going on. And breaking ranks, spilling the beans accidentally, could cost you and your company dearly. As in << deal of a lifetime … kind of thing >>. The longer the silence continues, the greater the risk of a leak. Then you have an uncontrollable situation that nobody wants. My suspicion is CEO Whelan waited until the silence became deafening for investors who, in turn, finally asked the question directly.
There are more than a few possibilities but, IN MY OPINION, the only truly qualifying event is a buyout (BO). Dare we consider multiple suitors? Another interpretation is having a production MOU agreement w/ Viant indicating a forthcoming need for large scale production in the very near future, e.g. - NPA. You must remember we are not selling product exclusively in the US, we have business relationships w/ companies, retail outlets and distributors around the world. Any potential BO candidate would be able to put all those under one roof, so to speak, and take care of all the necessary marketing to make Actipatch/RecoveryRx a household name.
There have been smaller, less noticeable clues to lead one to conclude there is much more happening under the surface than what appears. Like having a UPC code assigned to BIEL. Or BIEL making a 10 pack for hospitals. I have said before and I’ll say it again. BIEL is ripe for the picking right now, today, w/o any further development and/or marketing. But these things take time. Countless posters have laid out the case for BIEL to be acquired. Given the political climate and the tyrannical control TPTB have over medical practices, any potential buyer would necessarily have to tread very carefully. One, to maintain the element of surprise and, two, to reduce any possible outside influence to derail. Outside interference has occurred before and could very well rear its’ ugly head again. Lots of moving parts. The race is on.
Hope for the best, Prepare for the worst. Adapt - Improvise - OvercomeQuote:THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
"Sic parvis magma" - Greatness from small beginnings
All the best, WBeacham
3
